Ignoring the stock price of a company, what are the underlying trends that tell us a business is past the growth ...

Alzheimer's drug shows long-term benefits in behavior and cognition. EU approval of Blarcamesine could boost its market value ...

NET Power's $500M cash reserve and strategic plans face skepticism as stock plunges 85% amid zero revenue, high cash burn, ...

Sanofi is banking on the totality of data from the three phase 3 trials supporting potential filings for tolebrutinib, with the HERCULES result backed up by secondary endpoint data from the GEMINI ...

Benchmark indices Sensex and Nifty fell over 1% amid weak global cues and profit booking, extending losses for a third ...

XRP price climbed above the $2.35 level on Tuesday May 20, posting 1% gains on the 24-hour candle. On-chain data shows that ...

Buoyed by new results from a phase 1b/2a trial, Roche has said it plans to start a phase 3 programme for an Alzheimer's disease candidate from its Brainshuttle programme, a technology designed to ...

At COMPUTEX 2025 in Taipei, MSI rolled out a bunch of fresh hardware and some neat AI tools aimed at power users and ...

Stocks have bounced back after escalating tariffs and rising geopolitical concerns have given way to hope for a more stable ...

From major Gemini upgrades to new AI-powered Search features and 3D video calling, Google I/O keynote event detailed plans ...

The Titans are clearly committed to Cam Ward as their long-term quarterback, but head coach Brian Callahan isn’t rushing into ...

Quantum Machines’ open-source tool aims to standardize and accelerate calibration — a core bottleneck as quantum systems ...